Orcinol Glucoside Facilitates the Shift of MSC Fate to Osteoblast and Prevents Adipogenesis via WNT/Β-Catenin Signaling Pathway
Drug Design, Development and Therapy - New Zealand
doi 10.2147/dddt.s208458
Full Text
Open PDFAbstract
Available in full text
Date
August 1, 2019
Authors
Publisher
Informa UK Limited